145 related articles for article (PubMed ID: 22307913)
1. From bench to market: life science patents in Europe.
Rutz B
Biotechnol J; 2012 Feb; 7(2):171-5. PubMed ID: 22307913
[No Abstract] [Full Text] [Related]
2. Ordering life: law and the normalization of biotechnology.
Jasanoff S
Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485
[No Abstract] [Full Text] [Related]
3. Biotechnology--a challenge to the patent system.
Farnley S; Morey-Nase P; Sternfeld D
Curr Opin Biotechnol; 2004 Jun; 15(3):254-7. PubMed ID: 15193336
[TBL] [Abstract][Full Text] [Related]
4. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
5. EC biotechnology policy. Progress on animal patents.
Aldhous P
Nature; 1992 Jan; 355(6359):382. PubMed ID: 1734269
[No Abstract] [Full Text] [Related]
6. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
Paradise J
Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
[No Abstract] [Full Text] [Related]
7. The ethics of biotechnology.
Lenoir N
J Biolaw Bus; 2001; 4(2):6-10. PubMed ID: 12530386
[TBL] [Abstract][Full Text] [Related]
8. In search of a compromised solution to the problem arising from patenting biomedical research tools.
Derzko NM
Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840
[No Abstract] [Full Text] [Related]
9. Biotechnology products and university-based science.
Lempert P
JAMA; 2005 Jun; 293(23):2861-2; author reply 2863. PubMed ID: 15956627
[No Abstract] [Full Text] [Related]
10. Biotechnology products and university-based science.
Sobolski GK
JAMA; 2005 Jun; 293(23):2862; author reply 2863. PubMed ID: 15956629
[No Abstract] [Full Text] [Related]
11. Harmonization of biotechnological regulations in the European Community.
Sauer F
Bioprocess Technol; 1991; 13():455-68. PubMed ID: 1367146
[No Abstract] [Full Text] [Related]
12. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
13. Patents stalemate on biotechnology.
Butler D
Nature; 1994 Dec; 372(6505):393. PubMed ID: 7984224
[No Abstract] [Full Text] [Related]
14. Politicians seek to block human-gene patents in Europe.
Abbott A; Hellerer U
Nature; 2000 Apr; 404(6780):802. PubMed ID: 10819663
[No Abstract] [Full Text] [Related]
15. Much ado about gene patents: the role of foreseeability.
Gulliford MJ
Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
[No Abstract] [Full Text] [Related]
16. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
17. The MTA-rip it up and start again?
Ku K; Henderson J
Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290
[No Abstract] [Full Text] [Related]
18. Biotechnology products and university-based science.
Korn D; Heinig SJ
JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
[No Abstract] [Full Text] [Related]
19. To patent or not to patent: the European Union's new biotech directive.
Nenow L
Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115
[No Abstract] [Full Text] [Related]
20. Why the European Parliament rejected the patenting of human genes.
Grace M
Gene Ther; 1995 Oct; 2(8):509-11. PubMed ID: 8593600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
